SCHEMBL6101281

SCHEMBL6101281

Cc1ccc(Sc2ccc(S)c(C)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 2/20 0.42
▸ BCL2 P10415 1/20 0.42
▸ MLYCD O95822 1/20 0.39
▸ HPGD P15428 4/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ ATM Q13315 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ HKDC1 Q2TB90 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ HAO1 Q9UJM8 1/20 0.35
▸ OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16012706 0.91 ALDH1A1 (0.35) MCL1BCL2HPGDL3MBTL1ALDH1A1
SCHEMBL17835416 0.86 MAOA (0.43) MCL1BCL2HPGDALDH1A1KMT2A
SCHEMBL20345262 0.80 MAPT (0.49) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL12792110 0.80 MAPT (0.49) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL14479021 0.80 MLYCD (0.45) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL27813561 0.78 HSD17B10 (0.34) HPGDTDP1CYP1A2CYP3A4CYP2C9
SCHEMBL83853 0.76 ACHE (0.57) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL12245875 0.76 ACHE (0.57) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL11121834 0.76 ACHE (0.57) MCL1BCL2MLYCDHPGDL3MBTL1
SCHEMBL11589722 0.75 TP53 (0.58) MCL1BCL2MLYCDHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060111405-A1 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives GU LIANQUAN 2006-05-25 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111405-A1 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives PTGS2, PTGES2, PTGES MCL1 1772/4885BCL2 829/4885MLYCD 1749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback